SPR-397, 0.25% Ophthalmic Solution May Break the Inflammatory Cycle of Dry Eye Disease

被引：0
|
作者：
Crean, Christopher [1 ]
Dixon, Angela [1 ]
Cousin, Wendy [2 ]
Somaratne, Ransi [2 ]
机构：
[1] Xyzagen, Pittsboro, NC USA
[2] Spring Discovery, Palo Alto, CA USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Perfluorohexyloctane Ophthalmic Solution (Miebo) for Dry Eye Disease
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2024, 66 (1694): : 13 - 14
  • [2] Perfluorohexyloctane Ophthalmic Solution: A Review in Dry Eye Disease
    Amy Zhuang-Yan
    Yahiya Y. Syed
    Drugs, 2024, 84 : 441 - 448
  • [3] Perfluorohexyloctane Ophthalmic Solution: A Review in Dry Eye Disease
    Zhuang-Yan, Amy
    Syed, Yahiya Y.
    DRUGS, 2024, 84 (04) : 441 - 448
  • [4] Lifitegrast Ophthalmic Solution 5%: A Review in Dry Eye Disease
    Keating, Gillian M.
    DRUGS, 2017, 77 (02) : 201 - 208
  • [5] Lifitegrast Ophthalmic Solution 5%: A Review in Dry Eye Disease
    Gillian M. Keating
    Drugs, 2017, 77 : 201 - 208
  • [6] Lifitegrast Ophthalmic Solution 5% (Xiidra) for Dry Eye Disease
    Patel, Jay
    Franko, John
    AMERICAN FAMILY PHYSICIAN, 2018, 98 (02) : 119 - 120
  • [7] Inflammation in Dry Eye Disease How Do We Break the Cycle?
    Rhee, Michelle K.
    Mah, Francis S.
    OPHTHALMOLOGY, 2017, 124 (11) : S14 - S19
  • [8] Efficacy of Bromfenac Sodium Ophthalmic Solution for Treatment of Dry Eye Disease
    Fujishima, Hiroshi
    Fuseya, Miki
    Ogata, Masarou
    Murat, Dogru
    ASIA-PACIFIC JOURNAL OF OPHTHALMOLOGY, 2015, 4 (01): : 9 - 13
  • [9] Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye Disease
    Venkateswaran, Nandini
    Bian, Yandong
    Gupta, Preeya K.
    CLINICAL OPHTHALMOLOGY, 2022, 16 : 349 - 355
  • [10] Biochanin A: Disrupting the inflammatory vicious cycle for dry eye disease
    Chen, Taige
    Zhou, Nan
    Liang, Qi
    Li, Qi
    Li, Boda
    Chu, Yiran
    Zhang, Di
    Chen, Zeying
    Tsao, Jia-Ruei
    Feng, Xuebing
    Hu, Kai
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 977
12345